Comparison of the performance of laboratory tests in the diagnosis of feline infectious peritonitis by A. Stranieri et al.
Page 1 of 16 
Comparison of the performance of laboratory tests in the diagnosis of feline infectious 1 
peritonitis 2 
 3 
Angelica Stranieri, Alessia Giordano, Saverio Paltrinieri,
1
 Chiara Giudice, Valentina Cannito, 4 
Stefania Lauzi 5 
 6 
Department of Veterinary Medicine, University of Milan, Milan, Italy; Central Laboratory, 7 
Veterinary Teaching Hospital, University of Milan, Lodi, Italy. 8 
 9 
1
Corresponding author: Saverio Paltrinieri, Department of Veterinary Medicine, University of 10 
Milan, Via Celoria, 10 - 20133 Milan, Italy. saverio.paltrinieri@unimi.it 11 
 12 
Running head: Performances of tests for FIP 13 
14 
Page 2 of 16 
Abstract. We compared the performance of clinicopathologic and molecular tests for the 15 
antemortem diagnosis of feline infectious peritonitis (FIP). From 16 FIP and 14 non-FIP cats, 16 
we evaluated retrospectively the sensitivity, specificity, and likelihood ratios (LRs) of serum 17 
protein electrophoresis, α1-acid glycoprotein (AGP) on peripheral blood, screening reverse-18 
transcription nested PCR (RT-nPCR) on the 3’–untranslated region (3’-UTR), and spike (S) 19 
gene sequencing on peripheral blood, body cavity effusions, and tissue, as well as body cavity 20 
cytology and delta total nucleated cell count (∆TNC). Any of these tests on blood, and 21 
especially the molecular tests, may support or confirm a clinical diagnosis of FIP. A negative 22 
result does not exclude the disease except for AGP. Cytology, 3’-UTR PCR, and ∆TNC may 23 
confirm a clinical diagnosis on effusions; cytology or 3’-UTR PCR may exclude FIP. 24 
Conversely, S gene sequencing is not recommended based on the LRs. On tissues, S gene 25 
sequencing is preferable when histology is highly consistent with FIP, and 3’-UTR PCR when 26 
FIP is unlikely. Combining one test with high LR+ with one with low LR– (e.g., molecular 27 
tests and AGP on blood, ∆TNC and cytology in effusions) may improve the diagnostic power 28 
of the most used laboratory tests. 29 
 30 
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Feline infectious peritonitis (FIP) is a fatal disease of felids caused by a mutated feline 34 
coronavirus (FCoV) and its interaction with the immune response of the host.
14
 Several 35 
candidate genes have been investigated, but how their mutation contributes to the onset of FIP 36 
is not completely understood.
16
 37 
Two amino acid substitutions (mutation M1058L and S1060A) of the spike protein 38 
have been found in FCoVs from tissues of cats with FIP.
1
 These mutations were later 39 
associated with the systemic spread of the virus rather than with FIP, confirming that, to date, 40 
there are no tests that can differentiate enteric from pathogenic strains.
17,18
 Antemortem 41 
diagnosis relies on patient history and on the combination of different laboratory tests 42 
including serum protein electrophoresis (SPE), α1-acid glycoprotein (AGP) measurement, and 43 
analysis of body cavity effusions including evaluation of the delta total nucleated cell count 44 
(∆TNC) and the immunocytochemical staining of FCoVs in macrophages.
5,7,15,17
 Few studies 45 
have investigated the diagnostic potential of mutations in the spike (S) gene.
3,12
 Therefore, we 46 
compared the likelihood ratios (LRs) of clinicopathologic and molecular tests for the 47 
diagnosis of FIP. LRs are not influenced by the prevalence of disease and may be used to 48 
measure the increase or decrease in post-test probability of FIP. 49 
Results recorded on samples submitted to our diagnostic laboratory from 2013 to 2015 50 
were retrospectively analyzed and selected if samples fit the following criteria: 1) clinical 51 
suspicion of FIP, based on history and clinical signs including fever, lethargy, anorexia, 52 
weight loss, neurologic and/or ocular signs, and effusions; 2) availability of a final diagnosis 53 
as specified below; and 3) results of at least one clinicopathologic test (SPE and AGP on 54 
blood, cytology and ∆TNC on effusions) or reverse-transcription nested PCR (RT-nPCR) on 55 
the 3’–untranslated region (3’-UTR), and S gene sequencing on blood, effusions, and tissues. 56 
Because samples were analyzed for routine diagnostic purposes and collected under informed 57 
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consent of the owners, according to the guidelines of our Institution, a formal approval from 58 
the Ethical Committee was not required (EC decision 29 Oct 2012, protocol 02-2016). 59 
Cats were assigned to the FIP group if histopathologic findings revealed typical 60 
lesions along with positive immunohistochemistry (IHC) in at least one tissue.
11
 Cats were 61 
assigned to the non-FIP group when histology revealed diseases other than FIP along with 62 
negative IHC in all of the collected tissues, when follow-up demonstrated a complete 63 
recovery 18 mo from the first diagnosis, or when laboratory and imaging tests allowed 64 
diagnosis of a different disease. Euthanized cats were autopsied within 6 h. One specimen 65 
from all organs affected by gross anatomic lesions was collected, fixed in 10% buffered 66 
formalin, and embedded in paraffin. Another specimen from at least one affected organ 67 
(usually mesenteric lymph node) was immediately frozen at –80°C to perform both RT-nPCR 68 
for 3’-UTR and S gene sequencing. 69 
Histology was performed on 5-µm sections stained with hematoxylin and eosin. IHC 70 
was performed using a mouse monoclonal antibody anti-FCoV (FIPV3-70 clone, Serotec, 71 
Bio-Rad, Segrate, Italy) using protocols described in other studies.
9
 In FIP cats, IHC was 72 
performed on specimens with typical histologic lesions; in non-FIP cats, all of the collected 73 
tissues were tested with IHC as part of the routine autopsy in order to exclude the presence of 74 
FCoVs. 75 
Total proteins were measured spectrophotometrically using the biuret method (Cobas 76 
Mira, Roche, Basel, Switzerland), then SPE was performed on agarose gel using an 77 
automated analyzer (Hydrasis, Sebia Italia, Bagno a Ripoli, Italy) and a specific kit (Hydragel 78 
15 β1-β2, Sebia Italia) as described previously.
4
 79 
Serum AGP concentration was measured using a radial immunodiffusion kit (SRID, 80 
Tridelta Development, Bray, Ireland) as described previously.
15
 81 
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Fresh body cavity effusions were analyzed with a commercial analyzer (Sysmex XT-82 
2000iV, Sysmex Europe, Norderstedt, Denmark) to record the ∆TNC as reported previously.
5
 83 
Cytology was performed on smears stained with a rapid stain (Hemacolor, Merck, Darmstadt, 84 
Germany). 85 
Whole blood and effusions collected in EDTA were centrifuged (3,500 × g, 5 min) 86 
immediately upon receipt at the laboratory, within 12 h of collection. Pellets were suspended 87 
in 200 µL of phosphate-buffered saline and immediately stored at –20°C for RNA extraction. 88 
RNA was obtained (NucleoSpin RNA kit, Macherey-Nagel, Bethlehem, PA) 89 
according to the manufacturer’s instruction, and used for RT-nPCR analysis. FCoV presence 90 
was investigated in the pellets extracted from whole blood, effusions, or from tissues 91 
collected during autopsy (mesenteric lymph nodes in 25 cats, spleen in 3 cats, small intestine 92 
in 1 cat, lung in 1 cat) using RT-nPCR targeting a 177-bp product of the highly conserved 3’-93 
UTR.
8
 FCoV RNA was used as positive control and RNase-free water as negative control. 94 
PCR products were visualized under an ultraviolet transilluminator on 2% agarose gel stained 95 
with ethidium bromide. RNA was also tested using a RT-nPCR assay targeting a 142-bp 96 
product of the S gene.
1
 Positive samples were sequenced (Big Dye Terminator v.3.1 cycle 97 
sequencing kit, AB3730 DNA analyzer, Applied Biosystems, Foster City, CA), and forward 98 
and reverse primers were used for the second reaction. 99 
Sequence data were assembled and manually corrected (BioEdit software v.7.0, 100 
https://goo.gl/eDyNHn). Consensus sequences were aligned with FCoV strains bearing, or 101 
not, the mutations M1058L or S1060A, retrieved from GenBank (Clustal X, BioEdit 102 
software). 103 
Samples were classified as consistent with or not consistent with FIP according to 104 
study criteria (Table 1). Dubious features were considered “non-consistent with FIP” and 105 
included the lack of granular background in cytologic samples, ∆TNC values of 1.7–3.4 × 106 
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10
9
/L,
5
 increased serum α2-globulins but normal γ-globulins or vice-versa,
20
 or AGP values 107 
between 0.56 (reference value of the laboratory) and 1.5 g/L.
15
 When molecular tests were 108 
performed on >1 tissue specimen, cats were classified as positive when at least one of the 109 
tested organs provided a positive result, and negative when all of the specimens resulted 110 
negative (Table 2). 111 
For each test, true-positive and false-positive results (results consistent with FIP in 112 
cats with and without FIP, respectively) and true-negative and false-negative results (results 113 
not consistent with FIP in cats without and with FIP, respectively) were recorded. Sensitivity, 114 
specificity, as well as positive and negative LRs (LR+ and LR–, respectively) were then 115 
calculated.
2
 116 
Thirty cats (age: 4 mo to 13 y; median: 12 mo) suspected to have FIP were included in 117 
our study. The FIP group included 16 cats (age: 4–12 mo; median: 9 mo). The non-FIP group 118 
included 14 cats (age: 8 mo to 13 y; median: 5 y). In 3 cats in the non-FIP group, FIP was 119 
ruled out based on normalization of clinical and laboratory findings during an 18 mo follow-120 
up (cats 20–22, with persistent fever, inappetence, and lethargy); in 3 cats, a disease other 121 
than FIP was diagnosed through cytology, imaging, and flow cytometry (cat 24 with hepatic 122 
carcinoma, and cats 28 and 29, both with lymphoma); in 8 cats, postmortem findings were 123 
consistent with a disease other than FIP, and IHC was negative (cats 17–19, 23, 25–27, and 124 
30, with renal failure, pleuropericardial fibrosis, pleomorphic sarcoma, lymphocytic 125 
cholangitis, intestinal carcinoma, myelofibrosis, polycystic kidney disease, and lymphoma, 126 
respectively). 127 
All hematologic tests had high or absolute specificity and a high LR+, whereas 128 
sensitivity was low, except for AGP (Table 3). The very low sensitivity of SPE was caused by 129 
dubious or negative patterns, in accord with one study,
20
 but in disagreement with another 130 
report.
19
 Even if the high specificity was possibly the result of the relatively low number of 131 
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inflammatory conditions in the non-FIP group, the LR ratios indicate that SPE cannot 132 
definitely rule out FIP, but it may be used as a confirmatory test. 133 
AGP measurement had the highest sensitivity and LR+, even if lower than in a 134 
previous report,
6
 and the lowest LR–. Nevertheless, the false-negative cases had values 135 
consistent with inflammation and may support the diagnosis of FIP in conjunction with other 136 
consistent laboratory results. Interestingly, AGP showed also the lowest specificity but the 137 
LR– was low enough to recommend the use of this test to rule out FIP. On the other hand, 138 
based on the absolute specificity and on the relatively high LR–, the molecular tests cannot be 139 
used to rule out FIP, but they may support the diagnosis of FIP in the case of positive results. 140 
On effusions, all of the tests had high-to-absolute sensitivity and specificity and, 141 
consequently, high-to-absolute LR+ and low-to-excellent LR–, except for S gene sequencing, 142 
which had the worst performance in terms of sensitivity, LR+, and LR–. Cytology and the 143 
RT-nPCR 3’-UTR were the best tests on effusions, despite the presence of false-positive 144 
results. False-positive cytologic results may be explained by the fact that nonspecific 145 
inflammatory cytologic patterns are found in many inflammatory conditions,
13
 and that the 146 
virus can be found using immunofluorescence in the effusion of cats with diseases other than 147 
FIP.
17
 Therefore, in accord with previous reports, cytology and RT-nPCR 3’-UTR cannot be 148 
used to confirm FIP,
6,11
 but, based on their high LR+, these remain the tests of choice for 149 
effusions. The ∆TNC was specific but not as sensitive as expected, possibly given the low cell 150 
concentration of the samples with features that provided false-negative results, as noted in a 151 
previous study.
5
 Hence, ∆TNC may be used in addition to the other tests to support the 152 
diagnosis of FIP. 153 
Spike gene sequencing had low sensitivity. Moreover, one false-positive result was 154 
recorded, as described by others
18
 who found the S gene mutations described previously
1
 in 155 
tissues of cats without FIP, but in contrast to another report of absolute specificity of S gene 156 
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sequencing on effusions.
12
 Therefore, the risk of false-positive results, even if rare, make this 157 
test not optimal in the diagnosis of FIP. On tissues, the RT-nPCR 3’-UTR had the best, but 158 
not absolute, sensitivity and a low LR–, but also low specificity and low LR+. Conversely, S 159 
gene sequencing had high specificity and LR+ but lower sensitivity and slightly higher LR–. 160 
The negative results of this latter technique were the result not only of the absence of the 161 
mutated nucleotides, but also of negative results of the spike PCR (data not shown) and the 162 
resulting absence of sequencing templates. The low sensitivity of RT-nPCR 3’-UTR confirms 163 
a previous report regarding the spread of the virus in cats not affected by FIP and resulting 164 
false-positive results.
10
 On the other hand, the specificity of S gene sequencing was high, as 165 
on the other specimens. Thus, the risk of false-positive results with the RT-nPCR 3’-UTR is 166 
alarmingly high whereas the use of S gene sequencing can be useful as a confirmatory test, 167 
but its use for the exclusion of FIP should be avoided based on the results of our study. 168 
Summary information about the suggested clinical utility of each test to either confirm or 169 
exclude FIP is reported in Table 4. 170 
The limitations of our study are the low caseload, application of strict inclusion criteria 171 
that, however, increased the reliability of the results, and the low rate of inflammatory 172 
conditions in the non-FIP group that may have overestimated the specificity of tests 173 
suggestive of inflammation. However, we demonstrated that combining one test with high 174 
LR+ with one with low LR– (e.g., molecular tests and AGP on blood, ∆TNC and cytology on 175 
effusions) may improve diagnostic power. 176 
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Table 1. Study criteria of various laboratory tests to confirm or exclude feline infectious 239 
peritonitis (FIP) in 30 cats.
5,19-21,27
 240 
Specimen/Test Features and cutoffs consistent with FIP 
Effusion  
Cytology Presence of a nonspecific inflammatory process and of a 
proteinaceous background 
∆TNC  >3.4 × 10
9
/L 
RT-nPCR 3’-UTR Positive result  
S gene sequencing Presence of M1058L or S1060A mutations 
Blood  
SPE Increased α2- and γ-globulin with a polyclonal peak  
AGP >1.5 g/L  
RT-nPCR 3’-UTR Positive result  
S gene sequencing Presence of M1058L or S1060A mutations 
Tissues  
RT-nPCR 3’-UTR Positive result  
S gene sequencing Presence of M1058L or S1060A mutations 
AGP = α1-acid glycoprotein; RT-nPCR 3’-UTR = reverse-transcription nested PCR on the 3’–241 
untranslated region; S gene = spike gene; SPE = serum protein electrophoresis; ∆TNC = ratio 242 
between total nucleated cells counted on 2 channels of the Sysmex XT-2000iV. 243 
Page 13 of 16 
Table 2. Results of laboratory tests for feline infectious peritonitis (FIP) in 30 cats. 244 
Group/ID 
Blood Effusion Tissue 
SPE AGP 
RT-nPCR 
3’-UTR 
S gene 
seq Cytology ∆TNC 
RT-nPCR 
3’-UTR 
S gene 
seq 
RT-nPCR 
3’-UTR 
S gene 
seq 
FIP           
1 – – NP NP NP NP NP NP NP NP 
2* + + + – + – + – + – 
3 – + + + NP NP NP NP + + 
4* – + + + + + + + + + 
5 – – – – NP NP NP NP + + 
6* + + + + + + + + + + 
7* – + + – + + + – NP NP 
8* – + – NP + + + + + + 
9 + + NP NP NP NP NP NP NP NP 
10* – + + – NP + + – + + 
11* – + NP NP + + + – + – 
12* + + NP NP + + + – NP NP 
13* + + NP NP NP + + + + + 
14* NP NP NP NP NP – + – + – 
15 NP NP NP NP NP NP NP NP – NP 
16 + + NP NP NP NP NP NP NP NP 
Total positive results 6/14 12/14 6/8 3/7 7/7 8/10 10/10 4/10 10/11 7/10 
Non-FIP           
17 NP – NP NP NP NP NP NP + – 
18* – + NP NP – – – – – – 
19* – – – – – – – – + – 
20 – – – – NP NP NP NP NP NP 
21 – – – NP NP NP NP NP NP NP 
22 – – NP NP NP NP NP NP NP NP 
23 + + – – NP NP NP NP + + 
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24* NP NP NP NP – – – – NP NP 
25* – – NP NP + – + + – – 
26 NP NP – – NP NP NP NP – – 
27 NP NP NP NP NP NP NP NP + – 
28* – – – – – – – – NP NP 
29* – – – – – – – – NP NP 
30 – – – – NP NP NP NP – – 
Total positive results 1/10 2/11 0/8 0/7 1/6 0/6 1/6 1/6 4/8 1/8 
– = negative; + = positive; AGP= α1-acid glycoprotein; NP = not performed; RT-nPCR 3’-UTR = reverse-transcription nested PCR on the 3’–245 
untranslated region; S gene = spike gene; SPE = serum protein electrophoresis; ∆TNC = ratio between total nucleated cells counted on 2 246 
channels of the Sysmex XT-2000iV. 247 
* = Presence of effusion. 248 
 249 
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Table 3. Sensitivity, specificity, and positive and negative likelihood ratios of laboratory tests 250 
and sample types for feline infectious peritonitis in 30 cats. 251 
Specimen/Test Se (%) Sp (%) LR+ LR– 
Blood     
SPE 43 90 4.29 0.63 
AGP 86 82 4.71 0.17 
3’-UTR PCR 75 100 NC 0.25 
S gene sequencing 43 100 NC 0.57 
Effusions     
Cytology 100 83 6.00 0.00 
∆TNC 80 100 NC 0.20 
3’-UTR PCR 100 83 6.00 0.00 
S gene sequencing 40 83 2.40 0.72 
Tissues     
3’-UTR PCR 91 50 1.82 0.18 
S gene sequencing 70 88 5.60 0.34 
AGP = α1-acid glycoprotein; LR+ = positive likelihood rate; LR– = negative likelihood ratio; 252 
NC = not calculable based on 100% specificity; RT-nPCR 3’-UTR = reverse-transcription 253 
nested PCR on the 3’–untranslated region; S gene = spike gene; Se = sensitivity; Sp = 254 
specificity; SPE = serum protein electrophoresis; ∆TNC = ratio between total nucleated cells 255 
counted on 2 channels of the Sysmex XT-2000iV. 256 
257 
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Table 4. Recommended laboratory tests to confirm or exclude feline infectious peritonitis 258 
based on results in 30 cats. 259 
 Confirmatory test Exclusion test 
Blood SPE, RT-nPCR 3’-UTR, S gene sequencing AGP 
Effusions ∆TNC measurement, S gene sequencing Cytology, RT-nPCR 3’-UTR 
Tissues S gene sequencing RT-nPCR 3’-UTR 
AGP = α1-acid glycoprotein; RT-nPCR 3’-UTR = reverse-transcription nested PCR on the 3’–260 
untranslated region; S gene = spike gene; SPE = serum protein electrophoresis; ∆TNC = ratio 261 
between total nucleated cells counted on 2 channels of the Sysmex XT-2000iV. 262 
